News
FDA requests Moderna, Pfizer/BioNTech add safety warnings about myocarditis risk to COVID-19 vaccines, with specific rates ...
The FDA said it is making 'enhancements' designed to help states develop programs for importing cheaper drugs from Canada.
FTC sends new warning letters to Teva, Novartis, Amphastar, Viatris's Mylan, and Covis Pharma over allegedly improper drug ...
Eikon Therapeutics is laying off staff for the second time in 19 months, responding to 'changes in external circumstances' ...
The FDA’s Oncologic Drugs Advisory Committee voted 8-0 against a new indication for Pfizer’s Talzenna in combination with Xtandi for first-line treatment of adults with … Get free ...
BioNTech to invest £1B in UK R&D over 10 years, receives £129M government grant to build research centers and HQ in London, ...
Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...
Two weeks into his tenure leading the FDA’s biologics center, Vinay Prasad has made his mark with a new framework for ...
Moderna pulls BLA for its Covid-flu shot: The company suggested on its most recent … Get free access to a limited ...
Juvenescence is out with a $76 million Series B-1, its first equity funding since before the Covid-19 pandemic.
The gene editing company CRISPR Therapeutics surprisingly struck a deal with China-based biotech Sirius Therapeutics to ...
Biotech execs express concerns over FDA changes, NIH cuts, and Trump's tariffs. Industry confidence low amid poor funding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results